ClinicalTrials.Veeva

Menu

Virtual Reality Software for Patients With Stroke (RESET)

U

Universidad de Almeria

Status

Enrolling

Conditions

Stroke

Treatments

Device: META QUEST 3 virtual reality glasses
Other: Usual care
Device: Nintendo Switch (Nintendo Co., Ltd, Kyoto, Japan)

Study type

Interventional

Funder types

Other

Identifiers

NCT06132399
CPP2021-008497

Details and patient eligibility

About

The goal os this clinical trial is to develop and validate a gamified, fully immersive, and stroke-specific virtual reality software to improve physical disability and quality of life in patients with stroke.

The main questions it aims to answer are:

  • To assess the effects of a gamified, fully immersive and stroke-specific virtual reality 10-week intervention combined with usual care rehabilitation, compared to usual care rehabilitation alone and in combination with a commercially available VR system, on disability in patients with stroke.
  • To assess the effects of a gamified, fully immersive and stroke-specific virtual reality intervention combined with usual care rehabilitation, compared to usual care rehabilitation alone and in combination with a commercially available virtual reality system, on quality of life, upper-body motor function, gross manual dexterity, handgrip strength, static and dynamic balance, and cognitive function in patients with stroke

Full description

Stroke is the leading cause of long-term disability and ranks as the second most prevalent cause of mortality worldwide. According to data from the World Health Organization, since 2005, the global probability of a person experiencing a stroke has increased by 50 percent. It is expected that 1 in 4 individuals will face the risk of having a stroke in their lifetime. A stroke can result in significant loss of motor functions, communications abilities, weakness, or hemiparesis, leading to a diminished quality of life. Therefore, improving the rehabilitation process is evidently of paramount significance. Virtual reality has emerged as a novel strategy to improve neurological diseases; however, there is an absence of an immersive software designed specifically for stroke patients within a gamified environment. Therefore, the aim of RESET randomized controlled trial is to evaluate the effect of a gamified, fully immersive, and stroke-specific virtual reality software on disability in stroke patients.

Enrollment

96 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women and men with either an ischemic or hemorrhagic stroke
  • Stroke between the last 7 to 14 days
  • Functional independence before stroke (modified Rankin scale <3)
  • Paresis of the lower extremity, upper extremity, or both, with a score ≤3 on the "motor arm" item of the National Institutes of Health Stroke Scale (NIHSS) scale
  • Trunk control in seated and standing position
  • Ability to understand basic instructions and to decide whether to sign informed consent

Exclusion criteria

  • Moderate-severe aphasia that precludes understanding the required tasks
  • Cognitive impairment that precludes cooperation with tasks
  • Serious behavioral problems or mental disorders
  • Lower extremity deep vein thrombosis, quadriplegia, neurodegenerative diseases, lower limb fractures, or recent myocardial infarction
  • Vital organ (heart, lung, liver, kidney, etc.) failure, malignant tumor, or other unstable condition
  • A history of cerebrovascular disease (if not fully resolved)
  • Photosensitive epilepsy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

96 participants in 3 patient groups

Commercial non-immersive virtual reality group (CVR)
Active Comparator group
Description:
Nintendo Switch (Nintendo Co., Ltd, Kyoto, Japan).
Treatment:
Device: Nintendo Switch (Nintendo Co., Ltd, Kyoto, Japan)
Gamified, fully immersive and stroke-specific virtual reality group (RESET)
Experimental group
Description:
The RESET virtual reality software will be integrated in the META QUEST 3 glasses (Meta Platforms, San Francisco, CA, US).
Treatment:
Device: META QUEST 3 virtual reality glasses
Usual care (UC)
Active Comparator group
Description:
3 session/week of 90 minutes of physical therapy and occupational therapy.
Treatment:
Other: Usual care

Trial contacts and locations

4

Loading...

Central trial contact

Alberto Soriano-Maldonado, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems